Dr. Jane G. Boggs, MD

Dr. Boggs practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Boggs' NPI, 1245200294, was assigned on January 24, 2006. Dr. Boggs holds North Carolina license 2007-00521.

Dr. Boggs' primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Boggs' primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Boggs is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Boggs to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boggs practices, 4 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Boggs' primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Boggs is licensed in North Carolina.

CMS data shows 237 Medicare services from Dr. Boggs across 8 procedure codes in 2024, for 144 Medicare patients. Medicare paid $17,027 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Boggs in 2024. The largest group is 65 to 74, with 49 patients. 72% of them have high blood pressure, and 69% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boggs' median patient age at 67, with 59% women.

In 2024, Dr. Boggs wrote 971 Medicare Part D claims for 108 patients. 73% of them were for generic drugs. CMS names the drug for 844 of them, across 21 drugs with 11 or more claims each, at $335,955 in total drug cost. In 2023, CMS named 851 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Boggs for performance year 2024, reported as part of a group. Dr. Boggs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boggs as offering telehealth.

CMS Open Payments shows 28 general payments to Dr. Boggs from 11 drug and device companies from 2016 to 2025. Education make up the largest share, 45% of the total. Neuropace, Inc. paid the most, $4,509. It also lists 9 research payments totaling $7,827 from 2016 to 2018.